Axsome Therapeutics, Inc.

NasdaqGM:AXSM Rapport sur les actions

Capitalisation boursière : US$4.4b

Axsome Therapeutics Dividendes et rachats

Dividende contrôle des critères 0/6

Axsome Therapeutics n'a pas d'antécédents de versement de dividendes.

Informations clés

n/a

Rendement du dividende

-1.3%

Rendement des rachats

Rendement total pour l'actionnaire-1.3%
Rendement futur des dividendes0%
Croissance des dividendesn/a
Prochaine date de paiement du dividenden/a
Date ex-dividenden/a
Dividende par actionn/a
Ratio de distributionn/a

Mises à jour récentes sur les dividendes et les rachats

Pas de mise à jour

Recent updates

Axsome: AXS-07 And Its Upcoming Second PDUFA

Oct 15

Getting In Cheap On Axsome Therapeutics, Inc. (NASDAQ:AXSM) Might Be Difficult

Sep 06
Getting In Cheap On Axsome Therapeutics, Inc. (NASDAQ:AXSM) Might Be Difficult

Axsome's Auvelity: High Hopes Meet Hefty Bills (Rating Downgrade)

Aug 06

Axsome Therapeutics: Lots Of Moving Parts

Jul 23

Health Check: How Prudently Does Axsome Therapeutics (NASDAQ:AXSM) Use Debt?

Jul 02
Health Check: How Prudently Does Axsome Therapeutics (NASDAQ:AXSM) Use Debt?

Why Axsome Therapeutics Is A Promising Stock Pick In CNS Treatments

May 10

Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 09
Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Price In Tune With Revenues

Apr 13
Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Price In Tune With Revenues

Does Axsome Therapeutics (NASDAQ:AXSM) Have A Healthy Balance Sheet?

Mar 17
Does Axsome Therapeutics (NASDAQ:AXSM) Have A Healthy Balance Sheet?

Axsome: Unpacking Auvelity's First-Year Market Dynamics And Economic Challenges

Feb 21

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) P/S Is Still On The Mark Following 27% Share Price Bounce

Dec 27
Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) P/S Is Still On The Mark Following 27% Share Price Bounce

Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?

Dec 12
Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?

Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?

Sep 12
Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt In A Risky Way?

Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Price In Tune With Revenues

Aug 08
Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Price In Tune With Revenues

Upgrade: Analysts Just Made A Dazzling Increase To Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Forecasts

May 13
Upgrade: Analysts Just Made A Dazzling Increase To Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Forecasts

Earnings Update: Axsome Therapeutics, Inc. (NASDAQ:AXSM) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Mar 03
Earnings Update: Axsome Therapeutics, Inc. (NASDAQ:AXSM) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt Sensibly?

Mar 01
Is Axsome Therapeutics (NASDAQ:AXSM) Using Debt Sensibly?

Is Axsome Therapeutics (NASDAQ:AXSM) Weighed On By Its Debt Load?

Nov 14
Is Axsome Therapeutics (NASDAQ:AXSM) Weighed On By Its Debt Load?

Axsome Therapeutics: Clear Path Ahead For AXS07

Oct 05

Axsome to resubmit marketing application for migraine therapy in Q3 2023

Sep 29

Axsome: In The Middle Of Uncertainty Is Your Biggest Opportunity

Sep 16

Axsome begins enrolling in late-stage study of migraine drug AXS-07

Sep 01

Axsome gains 19% as FDA approves depression therapy

Aug 19

Axsome Therapeutics Q2 2022 Earnings Preview

Aug 08

Axsome: Breaking Bearish Trend

Jul 26

Axsome: One Step At A Time

Jul 01

Axsome And AXS-05: A Special Situation

May 02

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: Données insuffisantes pour déterminer si les dividendes par action de AXSM ont été stables dans le passé.

Dividende croissant: Données insuffisantes pour déterminer si les paiements de dividendes de AXSM ont augmenté.


Rendement des dividendes par rapport au marché

Axsome Therapeutics Rendement des dividendes par rapport au marché
Comment le rendement du dividende de AXSM se compare-t-il à celui du marché ?
SegmentRendement du dividende
Entreprise (AXSM)n/a
25% du marché (US)1.4%
25% du marché (US)4.4%
Moyenne du secteur (Pharmaceuticals)2.4%
Analyste prévisionnel (AXSM) (jusqu'à 3 ans)0%

Dividende notable: Impossible d'évaluer le rendement des dividendes de AXSM par rapport aux 25 % les moins bien payés par les actionnaires, car la société n'a signalé aucun versement récent.

Dividende élevé: Impossible d'évaluer le rendement des dividendes de AXSM par rapport aux 25 % des principaux payeurs de dividendes, car la société n'a signalé aucun versement récent.


Bénéfice distribué aux actionnaires

Couverture des revenus: Données insuffisantes pour calculer le ratio de distribution de AXSM afin de déterminer si les dividendes versés sont couverts par les bénéfices.


Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Impossible de calculer la durabilité des dividendes car AXSM n'a signalé aucun versement.


Découvrir des entreprises qui versent des dividendes élevés